SCHEMBL175220

SCHEMBL175220

CS(=O)(=O)CNc1ccc(C(=O)N2CCCC2c2ccccc2)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
ROCK2 O75116 5/20 0.45
PARP14 Q460N5 1/20 0.44
PARP10 Q53GL7 1/20 0.44
RIPK1 Q13546 1/20 0.43
SCD O00767 2/20 0.42
KCNK3 O14649 1/20 0.42
SCD5 Q86SK9 3/20 0.41
CCNC P24863 4/20 0.41
CDK8 P49336 4/20 0.41
EPHX2 P34913 2/20 0.40
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
JAK3 P52333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174021 0.82 TRPV1 (0.40) SCDCCNCCDK8
SCHEMBL716840 0.82 HSP90AA1 (0.45) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL175219 0.78 HSP90AA1 (0.47) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL717696 0.78 RIPK1 (0.45) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL164387 0.72 PARP14 (0.60) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL166794 0.70 ROCK2 (0.60) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL166963 0.69 RIPK1 (0.54) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL167323 0.69 HSP90AA1 (0.47) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL18283321 0.69 PREP (0.62) HSP90AA1HSP90AB1ROCK2PARP14PARP10
SCHEMBL715644 0.69 POLB (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed